Protara Therapeutics, Inc.

NASDAQ (USD): Protara Therapeutics, Inc. (TARA)

Last Price

5.17

Today's Change

+0.02 (0.38%)

Day's Change

5.05 - 5.19

Trading Volume

309,176

Overview

Market Cap

177 Million

Shares Outstanding

34 Million

Avg Volume

2,265,441

Avg Price (50 Days)

3.29

Avg Price (200 Days)

2.75

PE Ratio

-1.96

EPS

-2.64

Earnings Announcement

11-Mar-2025

Previous Close

5.15

Open

5.15

Day's Range

5.05 - 5.195

Year Range

1.595 - 10.48

Trading Volume

309,226

Price Change Highlight

1 Day Change

0.39%

5 Day Change

0.98%

1 Month Change

75.85%

3 Month Change

182.51%

6 Month Change

163.78%

Ytd Change

146.19%

1 Year Change

182.51%

3 Year Change

-20.34%

5 Year Change

-60.83%

10 Year Change

-98.68%

Max Change

-98.71%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment